The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignancies
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells
Vetro C;Romano A;ANCORA, FLAVIA;Coppolino F;Brundo M. V.;Raccuia SA;Tibullo D;La Cava P;Giallongo C;Parrinello NL
2015-01-01
Abstract
The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignanciesFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Vetro et al., 2015.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
129.21 kB
Formato
Adobe PDF
|
129.21 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
